Therapeutics: News and Research on Immunotherapy, Active

MeSH tree: E02.095.465.425.400.530

Severe COVID-19 may be a risk factor for multiple sclerosis

COVID-19 may be a risk factor for multiple sclerosis (MS). This has been shown by new research at Örebro University and Örebro University Hospital, Sweden. The study is published in the journal Brain Communications.

RSV hospitalizations linked to considerable burden in adults

Respiratory syncytial virus (RSV) is associated with a considerable burden of hospitalizations, intensive care unit (ICU) admissions, and in-hospital deaths among adults, according to a study published online Nov. 13 in JAMA ...

Mpox spread slows slightly in Africa

The spread of mpox has slowed down slightly across Africa but the epidemic is not over, the African Union's health watchdog said Thursday.

page 20 from 40